Ritual's HyaCera Reduces Wrinkles and Fine Lines to Improve Skin Smoothness

Before After 2
Photo courtesy of Ritual

Ritual has announced the completion of its clinical trial on HyaCera, the brand's daily skin support supplement. The clinical study conducted in partnership with a leading research organization shows that Ritual's HyaCera is proven to reduce wrinkles and fine lines and improve skin smoothness in 90 days.

The randomized, double-blind, placebo-controlled design, widely acknowledged as the gold standard in human research, spanned a duration of 12 weeks. Participants were 63 healthy women and men ranging in age from 26 to 64. Multiple skin-related assessments were made at baseline, 4 weeks, 8 weeks, and 12 weeks after the commencement of the supplementation protocol. At 12 weeks, results include a 356% reduction in crow's feet wrinkles within 90 days when compared to placebo and a 290% increase in facial skin smoothness within 90 days when compared to placebo. More HyaCera participants reported an improvement in skin elasticity, glow/radiance, fine lines and wrinkles and general signs of aging.*

"We were highly skeptical of creating a product for this category. We reviewed numerous ingredients, but either found ingredients with clinical studies that were poorly conducted or ingredients with no clinical support at all," said Adeline Grier-Welch MS, MPH, RDN, Senior Scientist at Ritual. "We selected Ceratiq® and Hyabest because they had human clinical evidence to support their efficacy, met our standards for traceability, and were ingredients we felt confident putting to the test in our own clinical trial."

"Selecting evidence-based ingredients has always been a priority for Ritual, and conducting a gold-standard clinical trial on the finished formula for HyaCera takes that commitment one step further. It provides robust scientific evidence on the efficacy of a skin supplement, a category that previously has had limited clinical support," said Mastaneh Sharafi PhD RD, Vice President of Scientific and Clinical Affairs at Ritual. "This clinical study not only reaffirms our dedication to producing high-quality products but also ensures that our customers can trust in the validated benefits of HyaCera™."

"It's important to me that we continue setting a new standard in the supplement industry. We've put a stake in the ground to conduct gold-standard human clinical trials in partnership with leading universities and research organizations from around the world on all our products by 2030," said Katerina Schneider, Founder and CEO of Ritual. "This is not a requirement in the category, but it's something we believe is important to ensure our customers can feel confident in the efficacy of the products they are using everyday."

More in Blemish Control